Award
Delivery Order #SPE2DR26F8FW8
Short-Term Delivery Order for NovoLog Insulin FlexPen by AmerisourceBergen
Buyer
Defense Logistics Agency
Award Amount
$852.48
Ceiling
$852.48
Awarded
March 06, 2026
Period of Performance
Mar 06, 2026 – Mar 09, 2026
Identifier
SPE2DR26F8FW8
NAICS
424210
This award is a delivery order contract granted to AmerisourceBergen Drug Corporation, a leading pharmaceutical distributor responsible for supplying medications and related healthcare services. The specific procurement involves providing NovoLog 100 Unit/mL FlexPen 3mL, a key pharmaceutical product used in diabetes management. The contract is a short-term, precise supply agreement aimed at fulfilling immediate medication needs within a narrow timeframe. This delivery order supports ongoing health service operations by ensuring timely access to critical pharmaceutical products. The contract was issued under an existing indefinite delivery vehicle (IDV) previously awarded to AmerisourceBergen, which facilitates pharmaceutical distribution nationwide. The contract was awarded through a competitive procurement vehicle, leveraging the established IDV framework to ensure efficiency and reliability. The performance period is brief, covering a span of just a few days in early March 2026, reflecting a focused, short-term delivery schedule. This award complements the long-term supply efforts under the IDV to streamline medication delivery and improve public health outcomes.
Description
4571064582!NOVOLOG 100 UNIT/ML FLEXPEN 3ML